Tumor control probability model for alpha-particle-emitting radionuclides

Radiation Research

Volumn 153, Issue 1, 2000, Pages 16-22

  Roeske, John C ^a   Stinchcomb, Thomas G ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b DEPAUL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE;

ALPHA RADIATION; ARTICLE; CANCER CONTROL; CELL SURVIVAL; DOSIMETRY; MODEL; PRIORITY JOURNAL; PROBABILITY; RADIATION ABSORPTION; RADIATION DOSE; STOCHASTIC MODEL; TARGET CELL; TUMOR GROWTH;

EID: 0034000456     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2000)153[0016:TCPMFA]2.0.CO;2     Document Type: Article

References (25)

1. R. M. Macklis, B. M. Kinscy, A. I. Kassis, J. L. M. Ferrara, R. W. Atcher, J. J. Hines, C. N. Coleman, S. J. Adelstein and S. J. Burahoff, Radioimmunotherapy with alpha-particle emitting immunoconjugates. Science 240, 1024-1026 (1988).
2. J. Rotmensch, J. L. Whitlock, J. L. Schwartz, J. J. Hines, R. C. Reba and P. V. Harper, In vitro and in vivo studies on the development of the alpha-emitting radionuclide bismuth 212 for intraperitoneal use against microscopic ovarian carcinoma. Am. J. Obstet. Gynecol. 176, 833-841 (1997).
3. M. R. Zalutsky, M. G. Stabin, R. H. Larsen and D. D. Bigner, Tissue distribution and radiation dosimetry of astatine-21 1-labeled chimeric 81C6, an alpha-particle-emitting immunoconjugate. Nucl. Med. Biol. 24, 255-261 (1997).
4. 213Bi - An alpha-particle emitter. Nucl. Med. Biol. 25, 241-246 (1998).
5. 211At in a murine intraperitoneal tumor model. Gynecol. Oncol. 57, 9-15 (1995).
6. 211At]astato-2′-deoxyuridine in human cancer cells. Int. J. Radiat. Biol. 72, 79-90 (1997).
7. R. H. Larsen, G. Akabani, P. Welsh and M. R. Zalutsky, The cytotoxicity and microdosimetry of astatine-21 1-labeled chimeric monoclonal antibodies in human glioma and melanoma cells in vitro. Radial. Res. 149, 155-162 (1998).
8. 211At: Analyses of tumor retention, microdistribution and growth delay. Br. J. Cancer 77, 1115-1122 (1998).
9. G. Vaidyanathan and M. Zalutsky, Targeted therapy using alpha emitters. Phys. Biol. Med. 41, 1915-1931 (1996).
10. M. R. McDevitt, G. Sgouros, R. D. Finn, J. L. Humm, J. G. Jurcic, S. M. Larson and D. A. Scheinbcrg, Radioimmunotherapy with alpha-emitting nuclides. Eur. J. Nucl. Med. 25, 1341-1351 (1998).
11. E. J. Hall, Radiobiology for the Radiologist, 2nd ed. Harper and Row, Hagerstown, MD, 1978.
12. K. Fujimori, D. G. Covell, J. E. Fletcher and J. N. Weinstein, Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab′)2 and fab in tumors. Cancer Res. 49, 5656-5663 (1989).
13. K. Fujimori, D. G. Covell, J. E. Fletcher and J. N. Weinstein, A modeling analysis of monoclonal antibody percolation through tumors: A binding site barrier J. Nucl. Med. 31, 1191-1198 (1990).
14. K. Fujimori, D. R. Fisher and J. N. Weinstein, Integrated microscopic-macroscopic pharmacology of monoclonal antibody radioconjugates: The radiation dose distribution. Cancer Res. 51, 4821-4827 (1991).
15. J. C. Roeske, G. T. Y. Chen, R. W. Atcher, C. A. Pelizzari, J. Rotmensch, D. Haraf, A. Montag and R. R. Weichselbaum, Modeling of dose to tumor and normal tissue from intraperitoneal radioimmunotherapy with alpha and beta emitters. Int. J. Radiat. Oncol. Biol. Phys. 19, 1539-1548 (1990).
16. J. L. Humm and L. M. Chin, A model of cell inactivation by internal alpha-particle emitters. Radiat. Res. 134, 143-150 (1993).
17. J. L. Humm, J. C. Roeske, D. R. Fisher and G. T. Y. Chen, Microdosimetric concepts in radioimmunotherapy. Med. Phys. 20, 535-541 (1993).
18. D. E. Charlton and R. A. Sephton, A relationship between microdosimetric spectra and cell survival for high-LET irradiation. Int. J. Radiat. Biol. 59, 447-457 (1991).
19. J. C. Roeske and T. G. Stinchcomb, Relationships between cell survival and specific energy spectra for therapeutic alpha-particle emitters. Radiat. Res. 145, 268-273 (1996).
20. 212Bi distributed in growth medium. Radiat. Prot. Dosim. 52, 311-315 (1994).
21. J. C. Roeske and T. G. Stinchcomb, The use of microdosimetric moments in evaluating cell survival for therapeutic alpha-particle emitters. Radiat Res. 151, 31-38 (1999).
22. T. G. Stinchcomb and J. C. Roeske, Analytic microdosimetry for radioimmunotherapeutic alpha emitters. Med. Phys. 19, 1385-1393 (1992).
23. T. R. Munro and C. W. Gilbert, The relation between tumour lethal doses and the radiosensitivity of tumour cells. Br. J. Radiol. 34, 246-251 (1961).
24. J. C. Roeske and T. G. Stinchcomb, A dosimetric framework for therapeutic alpha-particle emitters. J. Nucl. Med. 38, 1923-1929 (1997).
25. D. E. Charlton and M. S. Turner, Use of chord lengths through the nucleus to simulate the survival of mammalian cells exposed to high LET α-radiation. Int. J. Radiat. Biol. 69, 213-217 (1996).